Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionCresset Asset Management, LLC
Latest Disclosed Ownership64,181 shares
Latest Disclosed Value $ 8,944,829
Cresset Asset Management, LLC reports 3.92% increase in ownership of GILD / Gilead Sciences, Inc.

On May 15, 2026 - Cresset Asset Management, LLC filed a 13F-HR form disclosing ownership of 64,181 shares of Gilead Sciences, Inc. (CH:GILD) valued at $8,944,829 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 61,759 shares of Gilead Sciences, Inc.. This represents a change in shares of 3.92% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 64,181 2,422 3.92 8,945 17.99 0.0387
2026-02-17 2025-12-31 13F GILEAD SCIENCES COM 375558103 61,759 4,099 7.11 7,580 18.44 0.0319
2026-01-22 2025-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 57,660 3,836 7.13 6,400 7.26 0.0279
2025-11-12 2025-09-30 13F GILEAD SCIENCES COM 375558103 65,896 12,072 7,314 0.0275
2026-01-22 2025-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 53,824 -7,912 -12.82 5,967 -13.73 0.0297
2025-08-13 2025-06-30 13F GILEAD SCIENCES COM 375558103 63,790 2,054 7,073 0.0307
2025-05-13 2025-03-31 13F GILEAD SCIENCES COM 375558103 61,736 -15,218 -19.78 6,917 -2.69 0.0345
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 76,954 -74,671 -49.25 7,108 -44.08 0.0340
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 151,625 24,013 18.82 12,712 45.20 0.0489
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 127,612 31,695 33.04 8,755 24.63 0.0368
2024-05-15 2024-03-31 13F GILEAD SCIENCES COM 375558103 95,917 916 0.96 7,026 -8.72 0.0338
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 95,001 4,898 5.44 7,696 13.98 0.0460
2023-11-14 2023-09-30 13F GILEAD SCIENCES COM 375558103 90,103 -7,038 -7.25 6,752 -9.80 0.0261
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 97,141 78,956 434.18 7,487 396.42 0.0093
2023-05-12 2023-03-31 13F GILEAD SCIENCES COM 375558103 18,185 -3,556 -16.36 1,509 2.31 0.0302
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 21,741 -923 -4.07 1,475 5.44 0.0187
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 22,664 -1,904 -7.75 1,398 -7.66 0.0177
2022-08-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 24,568 -507 -2.02 1,514 1.61 0.0186
2022-05-16 2022-03-31 13F GILEAD SCIENCES COM 375558103 25,075 -15,414 -38.07 1,490 -49.32 0.0155
2022-02-10 2021-12-31 13F GILEAD SCIENCES COM 375558103 40,489 -95 -0.23 2,940 3.70 0.0284
2021-11-15 2021-09-30 13F GILEAD SCIENCES COM 375558103 40,584 7,094 21.18 2,835 22.99 0.0381
2021-08-10 2021-06-30 13F GILEAD SCIENCES COM 375558103 33,490 10,347 44.71 2,305 54.18 0.0327
2021-05-12 2021-03-31 13F GILEAD SCIENCES COM 375558103 23,143 2,679 13.09 1,495 25.42 0.0237
2021-02-11 2020-12-31 13F GILEAD SCIENCES COM 375558103 20,464 -4,652 -18.52 1,192 -24.89 0.0193
2020-11-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 25,116 -1,823 -6.77 1,587 -23.15 0.0296
2020-08-04 2020-06-30 13F GILEAD SCIENCES COM 375558103 26,939 8,035 42.50 2,065 46.14 0.0453
2020-05-15 2020-03-31 13F GILEAD SCIENCES COM 375558103 18,904 7,184 61.30 1,413 85.43 0.0430
2020-02-10 2019-12-31 13F GILEAD SCIENCES COM 375558103 11,720 3,429 41.36 762 45.14 0.0206
2019-11-13 2019-09-30 13F GILEAD SCIENCES COM 375558103 8,291 1,283 18.31 525 10.99 0.0161
2019-08-20 2019-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 7,008 -3,614 -34.02 473 -31.55 0.0147
2019-08-12 2019-06-30 13F GILEAD SCIENCES COM 375558103 7,008 -3,614 473
2019-05-15 2019-03-31 13F GILEAD SCIENCES COM 375558103 10,622 -611 -5.44 691 -1.71 0.0268
2019-05-21 2018-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 11,233 11,233 703 0.0417
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.